News | Artificial Intelligence | January 09, 2020

Amazon Chief Medical Officer to Speak at SCCT Artificial Intelligence in Cardiac CT Meeting

The SCCT Artificial Intelligence and Machine Learning in Cardiovascular CT meeting  will be held in New York City at the Marriott East Side, April 24-26, 2020. #SCCT

January 9, 2020 — Maulik Majmudar, M.D., chief medical officer at Amazon will be the keynote speaker at the upcoming Artificial Intelligence and Machine Learning in Cardiovascular CT meeting presented by the Society of Cardiovascular Computed Tomography (SCCT). Majumdar will be speaking on Amazon’s view of machine learning (ML) and artificial intelligence (AI) in healthcare at the conference, which will be held in New York City at the Marriott East Side, April 24-26, 2020.

Majumdar, a renowned cardiologist, left Massachusetts General Hospital to lead the tech giant in advancing and evolving the future of patient care. When asked why Silicon Valley is hiring so many cardiologists, he told MM&M in May 2019, “If you look at technological innovation over the years, cardiovascular medicine — above and beyond any other specialty — has probably seen the most, spanning all the way from new devices and diagnostics to clinical trials.” 

“Cardiovascular CT imagers must keep up with the latest advances in technology within the field in an effort to improve and maximize patient care,” explains Ed Nicol, M.D., MBA, FSCCT, of Royal Brompton Hospital in London, who led the organizing committee for the Artificial Intelligence and Machine Learning in Cardiovascular CT meeting. “Having Dr. Majmudar share his insights and perspective as a leader in this cutting edge field of healthcare technology is a tremendous honor.”

The Artificial Intelligence and Machine Learning in Cardiovascular CT meeting will bring together AI/ML developers, the clinical cardiovascular CT community and other relevant stakeholders to discuss the development, validation and clinical implementation of these technologies in cardiovascular medicine.

This meeting will focus on developments in AI and ML, that have the potential to impact on cardiovascular medicine and cardiovascular CT. Concentrating on the theme of coronary artery disease, will allow for in-depth discussion of clinical applications of these technologies with a wide range of stakeholders from the clinical, academic and commercial arenas.

To register or learn more about the Artificial Intelligence and Machine Learning in Cardiovascular CT meeting please visit https://scct.org/page/Innovation2020 and see full program, below.

For more information: www.SCCT.org

Related Content

Ultromics will offer EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.
An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients. #RSNA2020 #RSNA20 #RSNA

An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients.

Feature | Artificial Intelligence | December 02, 2020
December 2, 2020 – Automated deep learning analysis of abdominal...
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

News | Artificial Intelligence | November 24, 2020
November 24, 2020 — The U.S.
Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS.

Dia's LVivo artificial intelligence software can help automate many features of echocardiograms to speed workflow and aid novice users. The software is now integrated into the Konica Minolta Exa PACS. 

News | Artificial Intelligence | November 12, 2020
November 12, 2020 – Konica Minolta Healthcare Americas Inc. and DiA Imaging Analysis Ltd.
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.

Feature | Artificial Intelligence | September 29, 2020 | Joe Fornadel, J.D., and Wes Moran, J.D.
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady
Selfied might be used with AI to identify patients with heart disease. Getty Images

Getty Images

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Sending a photo selfie to the doctor could be a cheap and simple way of detecting heart disease usi
aption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.

Caption Health a leader in medical AI technology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an updated version of Caption Interpretation, which uses artificial intelligence (AI) to enable clinicians to obtain quick, easy and accurate measurements of cardiac ejection fraction (EF) at the point of care.

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — Caption Health a leader in medical AI technology, has received U.S.
In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

In February 2020, the U.S. Food and Drug Administration (FDA) cleared artificial intelligence software to assist in the acquisition of cardiac ultrasound images. The Caption Guidance software from Caption Health is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality. It is aimed at point of care ultrasound (POCUS) exams, where users may not be regular sonographers.

Feature | Artificial Intelligence | August 18, 2020 | Dave Fornell, Editor
The No.